These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11205462)

  • 81. The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum.
    Nguyen LN; Ha CS; Hess M; Romaguera JE; Manning JT; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1281-5. PubMed ID: 10889382
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.
    Velasquez WS; McLaughlin P; Fuller LM; Allen PK; Tucker SL; Swan F; Rodriguez MA; Hagemeister FB; Cabanillas FF
    Cancer; 1994 May; 73(9):2408-16. PubMed ID: 7513251
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Clinical significance of the t(14;18) and BCL2 overexpression in follicular large cell lymphoma.
    Weisenburger DD; Gascoyne RD; Bierman PJ; Shenkier T; Horsman DE; Lynch JC; Chan WC; Greiner TC; Connors JM; Vose JM; Armitage JO; Sanger WG
    Leuk Lymphoma; 2000 Feb; 36(5-6):513-23. PubMed ID: 10784396
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Salvage extended-field irradiation in follicular non-Hodgkin's lymphoma after failure of chemotherapy.
    Mahé Ma; Bourdin S; Le Pourhiet-Le Mevel A; Moreau P; Campion L; Hamidou M; Milpied N; Moreau A; Gaillard F; Harousseau JL; Cuillière JC
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):735-8. PubMed ID: 10837958
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Primary breast lymphoma: a pooled analysis of prognostic factors and survival in 93 cases.
    Liu MT; Hsieh CY; Wang AY; Pi CP; Chang TH; Huang CC; Huang CY
    Ann Saudi Med; 2005; 25(4):288-93. PubMed ID: 16212120
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Treatment of patients with lymphomas of the uterus or cervix with combination chemotherapy and radiation therapy.
    Stroh EL; Besa PC; Cox JD; Fuller LM; Cabanillas FF
    Cancer; 1995 May; 75(9):2392-9. PubMed ID: 7712450
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Primary follicular lymphoma of the gastrointestinal tract: a clinical and pathologic study of 26 cases.
    Shia J; Teruya-Feldstein J; Pan D; Hegde A; Klimstra DS; Chaganti RS; Qin J; Portlock CS; Filippa DA
    Am J Surg Pathol; 2002 Feb; 26(2):216-24. PubMed ID: 11812943
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after new induction regimen in patients with intermediate- and high-risk follicular lymphoma according to the follicular lymphoma international prognostic index: a multicenter, prospective phase II trial of the Spanish Lymphoma Oncology Group.
    Provencio M; Cruz Mora MÁ; Gómez-Codina J; Quero Blanco C; Llanos M; García-Arroyo FR; de la Cruz L; Gumá Padró J; Delgado Pérez JR; Sánchez A; Alvarez Cabellos R; Rueda A;
    Leuk Lymphoma; 2014 Jan; 55(1):51-5. PubMed ID: 23573825
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy?
    Chau I; Jones R; Cunningham D; Wotherspoon A; Maisey N; Norman AR; Jain P; Bishop L; Horwich A; Catovsky D
    Br J Cancer; 2003 Jul; 89(1):36-42. PubMed ID: 12838297
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed follicular lymphoma.
    Hiddemann W; Dreyling M; Stahel RA;
    Ann Oncol; 2005; 16 Suppl 1():i56-7. PubMed ID: 15888756
    [No Abstract]   [Full Text] [Related]  

  • 91. Survival after progression in patients with follicular lymphoma: analysis of prognostic factors.
    Montoto S; López-Guillermo A; Ferrer A; Camós M; Alvarez-Larrán A; Bosch F; Bladé J; Cervantes F; Esteve J; Cobo F; Colomer D; Campo E; Montserrat E
    Ann Oncol; 2002 Apr; 13(4):523-30. PubMed ID: 12056701
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Long-term outcomes for patients with limited-stage follicular lymphoma: update of a population-based study.
    Lo AC; Campbell BA; Pickles T; Aquino-Parsons C; Sehn LH; Connors JM; Savage KJ
    Blood; 2020 Aug; 136(8):1006-1010. PubMed ID: 32321165
    [No Abstract]   [Full Text] [Related]  

  • 93. Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma.
    Sha F; Okwali M; Alperovich A; Caron PC; Falchi L; Hamilton A; Hamlin PA; Horwitz SM; Joffe E; Khan N; Kumar A; Matasar MJ; Moskowitz AJ; Noy A; Owens C; Palomba LM; Rodriguez-Rivera I; Straus D; von Keudell G; Zelenetz AD; Yahalom J; Dogan A; Schöder H; Seshan VE; Salles G; Younes A; Batlevi CL
    Blood Cancer J; 2022 Feb; 12(2):29. PubMed ID: 35145059
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Favorable long-term outcome with mistletoe therapy in a patient with centroblastic-centrocytic non-Hodgkin lymphoma].
    Kuehn JJ
    Dtsch Med Wochenschr; 1999 Nov; 124(47):1414-8. PubMed ID: 10605421
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Risk Factors Analysis of Thromboembolism in Patients with Lymphoma Chemotherapy].
    Li X; Hou SL; Li X; Li L; Lian K; Cui JY; Wang GG; Yang T
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):131-135. PubMed ID: 35123615
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Chemotherapy-free regimens in frontline follicular lymphoma.
    Batlevi CL
    Blood; 2022 Apr; 139(15):2263-2264. PubMed ID: 35420687
    [No Abstract]   [Full Text] [Related]  

  • 97. Measurable residual disease-driven therapy after radiotherapy for early-stage follicular lymphoma.
    Gunther JR; Pinnix CC
    Lancet Haematol; 2024 Jul; 11(7):e472-e473. PubMed ID: 38937019
    [No Abstract]   [Full Text] [Related]  

  • 98. Risk Factors of Thromboembolism in Lymphoma Patients Undergoing Chemotherapy and its Clinical Significance.
    Li X; Hou SL; Li X; Li L; Lian K; Cui JY; Wang GG; Yang T
    Clin Appl Thromb Hemost; 2021; 27():10760296211037923. PubMed ID: 34498533
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Follow-up of water-only fasting and an exclusively plant food diet in the management of stage IIIa, low-grade follicular lymphoma.
    Myers TR; Zittel M; Goldhamer AC
    BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30093470
    [No Abstract]   [Full Text] [Related]  

  • 100. Risk-adapted therapy in follicular lymphoma: Is it time to "FLEX"?
    Tobin JWD; Gandhi MK
    Am J Hematol; 2020 Dec; 95(12):1454-1456. PubMed ID: 33031592
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.